Read Anywhere and on Any Device!

Special Offer | $0.00

Join Today And Start a 30-Day Free Trial and Get Exclusive Member Benefits to Access Millions Books for Free!

Read Anywhere and on Any Device!

  • Download on iOS
  • Download on Android
  • Download on iOS

Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation

Michael D. Green
4.9/5 (30314 ratings)
Description:Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period. Michael D. Green offers a comprehensive overview of the Benedictin case and highlights many of the key issues in mass toxic substances litigation, comparing individual and collective forms of litigation, and illustrating the misunderstandings between scientists and lawyers about the role of science in providing evidence for the legal system.We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation. To get started finding Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation, you are right to find our website which has a comprehensive collection of manuals listed.
Our library is the biggest of these that have literally hundreds of thousands of different products represented.
Pages
384
Format
PDF, EPUB & Kindle Edition
Publisher
University of Pennsylvania Press
Release
1998
ISBN
0812216458

Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation

Michael D. Green
4.4/5 (1290744 ratings)
Description: Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period. Michael D. Green offers a comprehensive overview of the Benedictin case and highlights many of the key issues in mass toxic substances litigation, comparing individual and collective forms of litigation, and illustrating the misunderstandings between scientists and lawyers about the role of science in providing evidence for the legal system.We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation. To get started finding Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation, you are right to find our website which has a comprehensive collection of manuals listed.
Our library is the biggest of these that have literally hundreds of thousands of different products represented.
Pages
384
Format
PDF, EPUB & Kindle Edition
Publisher
University of Pennsylvania Press
Release
1998
ISBN
0812216458
loader